Towards Pharma 4.0 in clinical trials: a future-orientated perspective

Hariry, R.E., Vatankhah Barenji, R. ORCID: 0000-0003-2933-0954 and Paradkar, A., 2022. Towards Pharma 4.0 in clinical trials: a future-orientated perspective. Drug Discovery Today, 27 (1), pp. 315-325. ISSN 1359-6446

[img] Text
1536370_Barenji.pdf - Post-print
Full-text access embargoed until 16 September 2022.

Download (631kB)

Abstract

Pharma 4.0, a technology ecosystem in drug development analogous to Industry 4.0 in healthcare, is transforming the traditional approach to drug discovery and development, aligning product quality with less time to market, and creating intelligent stakeholder networks through effective collaborations. The wide range of potential Pharma 4.0 networks have produced several conceptualizations, which have led to a lack of clarity and definition. The main emphasis of this paper is on the clinical trial stage of drug development in the Pharma 4.0 era. It highlights the merged computerized technologies that are currently used in clinical research, and proposes a framework for integrating Pharma 4.0 technologies. The impact of and barriers to employing the proposed framework are discussed, highlighting its potential and some future research applications.

Item Type: Journal article
Publication Title: Drug Discovery Today
Creators: Hariry, R.E., Vatankhah Barenji, R. and Paradkar, A.
Publisher: Elsevier BV
Date: January 2022
Volume: 27
Number: 1
ISSN: 1359-6446
Identifiers:
NumberType
10.1016/j.drudis.2021.09.002DOI
1536370Other
Divisions: Schools > School of Science and Technology
Record created by: Jeremy Silvester
Date Added: 08 Apr 2022 15:14
Last Modified: 08 Apr 2022 15:14
URI: http://irep.ntu.ac.uk/id/eprint/46080

Actions (login required)

Edit View Edit View

Views

Views per month over past year

Downloads

Downloads per month over past year